J. Meireles-Brandao/LinkedIn
Jul 5, 2026, 20:22
J. Meireles-Brandao: Exploring the Approach to Thrombophillias
J. Meireles-Brandao, Associate at SEDES – Association for Economic and Social Development, shared a post on LinkedIn:
“Thrombophilias | CVR | MVR | CVD
An imminent, yet rarely discussed, vascular risk.
It affects approximately 15% of the Caucasian population, either genetically or epigenetically.
Diagnoses typically occur after events.
Frequently associated with lipoprotein disease.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t
-
Jul 5, 2026, 20:00Paul Kariuki: Why Altruism Isn’t Enough to Save Kenya’s Blood System
-
Jul 5, 2026, 19:53Tareq Abadl: Post-Transfusion Reactions – Can You Identify the Cause?
-
Jul 5, 2026, 19:46Nawsherwan Mohammad: Exploring Thrombophilia in 2026
-
Jul 5, 2026, 19:35Luise Erpenbeck: When Immune Cells Speak the Language of Neurons
-
Jul 5, 2026, 19:14Mubariz Ahsan: Bringing Stroke Research to a Wider Audience
-
Jul 5, 2026, 18:58Linda Hayes Bennett: Redefining Ferroptosis in Aging and Neurodegenerative Conditions
-
Jul 5, 2026, 18:20LV Aneurysm, Thrombus, and Embolism: A Silent Post-MI Threat – Abdallah Othman
-
Jul 5, 2026, 17:58Andaleb Kholmukhamedov: What’s the Most Unusual “False Positive” Trigger You’ve Seen Elevate a D-Dimer?